115372 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66748)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5599)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115372)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC): NRG Oncology/NSABP B-51/RTOG 1304
    Meeting Abstract

    Mamounas, E. P.; Bandos, H.; White, J. R.; Julian, T. B.; Khan, A. J.; Shaitelman, S. F.; Torres, M. A.; Vicini, F. A.; Ganz, P. A.; McCloskey, S. A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard peri-operative care in women with residual triple negative early stage/resectable breast cancer after standard-of-care neoadjuvant chemotherapy
    Meeting Abstract

    McArthur, H. L.; Comen, E. A.; Solomon, S.; Rodine, M.; DiLauro Abaya, C.; Leal, J. H. S.; Patil, S.; Norton, L.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Lymphedema management in 2018: Are we making any progress?
    Meeting Abstract

    Mehrara, B.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Activity of larotrectinib, a highly selective inhibitor of tropomyosin receptor kinase, in TRK fusion breast cancers
    Meeting Abstract

    Meric-Bernstam, F.; Shukla, N.; Peled, N.; Landman, Y.; Onitilo, A.; Montez, S.; Ku, N. C.; Hyman, D. M.; Drilon, A.; Hong, D. S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-low expressing breast cancer: Updated results of a large phase 1 study
    Meeting Abstract

    Modi, S.; Tsurutani, J.; Tamura, K.; Park, H.; Sagara, Y.; Murthy, R.; Iwata, H.; Krop, I. E.; Doi, T.; Redfern, C.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Risk of contralateral breast cancer (CBC) in women with ductal carcinoma in situ (DCIS) with and without and synchronous lobular carcinoma in situ (LCIS)
    Meeting Abstract

    Miller, M. E.; Muhsen, S.; Zabor, E. C.; Flynn, J.; Olcese, C.; Giri, D.; Van Zee, K. J.; Pilewskie, M.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase 1/1b study of novel oral selective estrogen receptor degrader (SERD) LSZ102 for estrogen receptor-positive (ER plus ) advanced breast cancer (ABC) with progression on endocrine therapy (ET)
    Meeting Abstract

    Jhaveri, K.; Curigliano, G.; Yap, Y. S.; Cresta, S.; Duhoux, F. P.; Terret, C.; Takahashi, S.; Ulaner, G. A.; Kundamal, N.; Baldoni, D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Local transdermal therapy (LTT): Drug permeation and distribution of telapristone acetate (TPA) in a pre-surgical window study of women undergoing mastectomy
    Meeting Abstract

    Lee, O.; Pilewskie, M.; Xu, Y.; Benante, K.; Blanco, L.; Helenowski, I.; Tull, M. B.; Muzzio, M.; Jovanovic, B.; Karlan, S.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • The CHANCE study: Mechanical skin changes among women with non-metastatic breast cancer receiving chemotherapy and endocrine therapy
    Meeting Abstract

    Lacouture, M. E.; Phillips, G. S.; Freites-Martinez, A.; Patil, S.; Samuels, A.; Shapiro, J.; Kukoyi, O.; Goldfarb, S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase 1/2 study of topical SOR007 (nanoparticle paclitaxel ointment) for cutaneous metastasis
    Meeting Abstract

    Lang, J. E.; Chawla, S.; Chang, J.; diZerega, G.; Cavanna-Mast, R. M.; Savoie, C.; Lacouture, M.
    Cancer Research (2019)

    Fulltext@MSK | Save